Bernd Kallmünzer

TL;DR: In patients with a recent history of embolic stroke of undetermined source, dabigatran was not superior to aspirin in preventing recurrent stroke, but there were more clinically relevant nonmajor bleeding events in the dabig atran group.

TL;DR: These data demonstrate and quantify decreasing hospital admissions due to ischemic cerebrovascular events and suggest that this may be a consequence of social distancing measures, in particular because hospital resources for acute stroke care were not limited during this period.

TL;DR: The risk for significant cardiac arrhythmia after an acute cerebrovascular event is highest after the first 24 hours of care and declines with time during the first 3 days and along with established vascular risk factors may be considered for a stratified allocation of monitoring capabilities.

TL;DR: In patients who have had a stroke with unknown time of onset with a DWI-FLAIR or perfusion mismatch, intravenous alteplase resulted in better functional outcome at 90 days than placebo or standard care despite an increased risk of symptomatic intracranial haemorrhage.

TL;DR: It is not known whether patients with atrial fibrillation with ischemic stroke despite oral anticoagulant therapy are at increased risk for further recurrent strokes or how ongoing secondary prevention should be managed.